So widespread is IP abuse that it no longer is regarded as a crime by many of the people committing it or authorities entrusted to
So widespread is IP abuse that it no longer is regarded as a crime by many of the people committing it or authorities entrusted to
An article summarizing inventor Robert Kearns’ epic battle against the automobile industry is this year’s most read IP CloseUp post with more than 21,000 visits.
There are abundant statistics on the cost of counterfeit goods, copyright infringement and even the negative impact of patent “trolls,” but nothing on the estimated
Can businesses and entrepreneurs compete with weaker U.S. patents in an innovation-driven global economy? An event featuring a broad range of IP thought-leaders on October
Consulting giant Accenture has rattled the cage of the fintech community by filing a patent for an “editable” blockchain that would allow a central administrator
The race is on to gain control of a new technology that has the power to reinvent banking and make transactions and other agreements between parties
Taylor Swift, a pop star with sufficient power to move mountains, succeeded in moving an equally resolute object last year: Apple Music’s position on paying royalties to
Stopping new inventions dead in their tracks by making them “automatically” unpatentable might sound like a good idea to some. However, programming a computer to
IP², an initiative of the Hoover Institution at Stanford University, last week hosted a more than 60 IP scholars, economists and practitioners to hear and challenge research
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over